Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy

被引:132
作者
Cervenakova, L
Yakovleva, O
McKenzie, C
Kolchinsky, S
McShane, L
Drohan, WN
Brown, P
机构
[1] Amer Red Cross, Jerome H Holland Lab Biomed Sci, Plasma Derivat Dept, Rockville, MD 20855 USA
[2] NCI, Biometr Res Branch, NIH, Bethesda, MD 20892 USA
[3] NIH, Lab CNS Studies, Bethesda, MD 20892 USA
关键词
D O I
10.1046/j.0041-1132.2003.00586.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The possible transmission of variant CJD (vCJD) through blood transfusion or use of plasma-derived products prompted this study comparing infectivity in murine models of vCJD and Gerstmann-Straussler-Scheinker (GSS) disease, a non-vCJD form of transmissible spongiform encephalopathy (TSE). STUDY DESIGN AND METHODS: RIII/Fa/Dk (RIII) or Swiss-Webster (Swiss) mice were inoculated intracerebrally (IC) with mouse-adapted strains of vCJD or GSS (Fukuoka-1) of similar infectivity. Groups of RIII mice were euthanized 17 weeks after inoculation (during the incubation period), and another 23 weeks after inoculation (when symptomatic). Blood was collected, separated into components, and inoculated into groups of healthy mice; brains and spleens from all mice were harvested and tested for the presence of PrPres by Western blot using 6H4 MoAb. RESULTS: Levels of 20-30 infectious doses per mL were present in buffy coat and plasma during both the incubation and symptomatic stages of disease; PLT pellet infectivity was lower (10 ID/mL) and RBCs were not infectious. The disease was transmitted more efficiently by IV than IC inoculation of plasma, but there was no difference observed with inoculation of buffy coat. The incubation period was shorter after IC inoculation of GSS- than vCJD-brain inocula. The amount of PrPres in spleens was similar for both TSE agents, but was slightly lower in brains of vCJD than GSS mice. CONCLUSION: Infectivity was detected in blood components of mice infected with a human-derived strain of vCJD during both the preclinical and clinical phases of disease in a similarly low range of concentrations as in mice infected with a human-derived nonvariant strain (GSS, Fukuoka-1). Other measures of virulence, including brain infectivity titers, incubation periods, and the accumulation of PrPres in spleens and brains, were also comparable in both experimental models.
引用
收藏
页码:1687 / 1694
页数:8
相关论文
共 26 条
  • [1] Deaths from variant Creutzfeldt-Jakob disease in the UK
    Andrews, NJ
    Farrington, CP
    Ward, HJT
    Cousens, SN
    Smith, PG
    Molesworth, AM
    Knight, RSG
    Ironside, JW
    Will, RG
    [J]. LANCET, 2003, 361 (9359) : 751 - 752
  • [2] BSE priors propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein
    Asante, EA
    Linehan, JM
    Desbruslais, M
    Joiner, S
    Gowland, I
    Wood, AL
    Welch, J
    Hill, AF
    Lloyd, SE
    Wadsworth, JDF
    Collinge, J
    [J]. EMBO JOURNAL, 2002, 21 (23) : 6358 - 6366
  • [3] Variant CJD transmission through blood: risks to predictors and "predictees"
    Brown, P
    [J]. TRANSFUSION, 2003, 43 (04) : 425 - 427
  • [4] Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans
    Brown, P
    Cervenáková, L
    McShane, LM
    Barber, P
    Rubenstein, R
    Drohan, WN
    [J]. TRANSFUSION, 1999, 39 (11-12) : 1169 - 1178
  • [5] The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy
    Brown, P
    Rohwer, RG
    Dunstan, BC
    MacAuley, C
    Gajdusek, DC
    Drohan, WN
    [J]. TRANSFUSION, 1998, 38 (09) : 810 - 816
  • [6] Detection of variant Creutzfeld-Jakob disease infectivity in extraneural tissues
    Bruce, ME
    McConnell, I
    Will, RG
    Ironside, JW
    [J]. LANCET, 2001, 358 (9277) : 208 - 209
  • [7] Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent
    Bruce, ME
    Will, RG
    Ironside, JW
    McConnell, I
    Drummond, D
    Suttie, A
    McCardle, L
    Chree, A
    Hope, J
    Birkett, C
    Cousens, S
    Fraser, H
    Bostock, CJ
    [J]. NATURE, 1997, 389 (6650) : 498 - 501
  • [8] Factor VIII and transmissible spongiform encephalopathy: the case for safety
    Cervenakova, L
    Brown, P
    Hammond, DJ
    Lee, CA
    Saenko, EL
    [J]. HAEMOPHILIA, 2002, 8 (02) : 63 - 75
  • [9] Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD
    Collinge, J
    Sidle, KCL
    Meads, J
    Ironside, J
    Hill, AF
    [J]. NATURE, 1996, 383 (6602) : 685 - 690
  • [10] Drohan WN, 1999, THROMB HAEMOSTASIS, V82, P486